Chemokine (C-X-C motif) ligand 2 (Cxcl2), S100 calcium binding protein A8 (S100a8), and S100 calcium binding protein A9 (S100a9), which were elevated in obesity but decreased following semaglutide treatment, were also expressed particularly in neutrophils
Quick Answer: Semaglutide does not cause systemic bruising as a recognized side effect, though localized bruising may occur at injection sites with subcutaneous formulations due to minor needle trauma
Osmotic laxatives including polyethylene glycol 3350 (MiraLAX), lactulose, and magnesium hydroxide (Milk of Magnesia) are another reasonable option
Case Overview Ozempic is a GLP-1 agonist drug intended to treat diabetes
Ozempic (semaglutide) stays in your system for approximately 5 weeks after your last injection
Thus, PIONEER 8 trial establishes that oral semaglutide can be safe and effective even in the late stage of diabetes